ClinConnect ClinConnect Logo
Search / Trial NCT01073072

Study Comparing Tutomesh® Repair to Conventional Surgical Techniques in Potentially Contaminated Hernia Repair and Abdominal Wall Reconstruction

Launched by CENTRE HOSPITALIER RÉGIONAL UNIVERSITAIRE MONTPELLIER · Feb 22, 2010

Trial Information

Current as of June 07, 2025

Completed

Keywords

Bovine Pericardium Bioprosthesis Contamination Hernia Repair Abdominal Wall Reconstruction Tutomesh Tutopatch Potentially Contaminated Hernia Repair Potentially Contaminated Abdominal Wall Reconstruction

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patient presenting with an incisional hernia or complicated hernia contraindicating the use of non absorbable mesh:
  • Infected incisional hernia: abdominal wall abscess, chronic fistula
  • Incisional hernia with high septic potential: incisional hernia with strangulation of one or more intestinal loops, repair of incisional hernia during surgery requiring opening of the digestive tube (digestive resection, restoration of digestive continuity, gastro-intestinal perforation, peritonitis from digestive origin)
  • Recurrent incisional hernia with problem of cutaneous healing
  • Incisional hernia requiring important intestinal adhesiolysis
  • Patients signing informed consent form after reading and understanding the information letter _ Patients are more than 18 year old
  • Exclusion Criteria:
  • Patient with major anesthetic risk (ASA 4)
  • Patient suffering from immunodepression or under immunosuppressor treatment (corticoids...)
  • Patients already enrolled in another study
  • Patient suffering from severe disease not allowing a 1-year follow-up
  • Patient refusing to be enrolled after consulting the information letter
  • Patient presenting with a too large incisional hernia, superior to 140x200 mm
  • Pregnancy

About Centre Hospitalier Régional Universitaire Montpellier

The Centre Hospitalier Régional Universitaire (CHRU) Montpellier is a leading academic hospital located in Montpellier, France, renowned for its commitment to advanced patient care, innovative research, and medical education. As a prominent clinical trial sponsor, CHRU Montpellier actively engages in a wide array of clinical studies across various medical disciplines, striving to enhance therapeutic outcomes and contribute to the body of scientific knowledge. The institution's multidisciplinary approach fosters collaboration among healthcare professionals, researchers, and industry partners, ensuring the implementation of cutting-edge methodologies and adherence to the highest ethical standards in clinical research.

Locations

Amiens, , France

Nantes, , France

Toulouse, , France

Marseille, , France

Beziers, , France

Aix En Provence, , France

Antibes, , France

Aubagne, , France

Avignon, , France

Bondy, , France

Fréjus, , France

Grenoble La Tronche, , France

Montpellier, , France

Nice, , France

Nimes, , France

Paris, , France

Salon De Provence, , France

Strasbourg, , France

Tours, , France

Patients applied

0 patients applied

Trial Officials

David Nocca, Dr

Principal Investigator

University Hospital, Montpellier

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials